These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 38966644)
21. Innate and adaptive immune responses in respiratory virus infection: implications for the clinic. Stambas J; Lu C; Tripp RA Expert Rev Respir Med; 2020 Nov; 14(11):1141-1147. PubMed ID: 32762572 [TBL] [Abstract][Full Text] [Related]
22. Role of IL-15 and IL-21 in viral immunity: applications for vaccines and therapies. Rodrigues L; Bonorino C Expert Rev Vaccines; 2009 Feb; 8(2):167-77. PubMed ID: 19196197 [TBL] [Abstract][Full Text] [Related]
23. OASL-a new player in controlling antiviral innate immunity. Zhu J; Ghosh A; Sarkar SN Curr Opin Virol; 2015 Jun; 12():15-9. PubMed ID: 25676874 [TBL] [Abstract][Full Text] [Related]
24. IL-10: A Multifunctional Cytokine in Viral Infections. Rojas JM; Avia M; Martín V; Sevilla N J Immunol Res; 2017; 2017():6104054. PubMed ID: 28316998 [TBL] [Abstract][Full Text] [Related]
25. Induction and function of virus-specific CD4+ T cell responses. Whitmire JK Virology; 2011 Mar; 411(2):216-28. PubMed ID: 21236461 [TBL] [Abstract][Full Text] [Related]
26. Antiviral Activities of Interleukin-27: A Partner for Interferons? Amsden H; Kourko O; Roth M; Gee K Front Immunol; 2022; 13():902853. PubMed ID: 35634328 [TBL] [Abstract][Full Text] [Related]
27. [Interleukin-21: a key cytokine for controlling HIV and other chronic viral infections]. Iannello A; Allam O; Samarani S; Ahmad A Med Sci (Paris); 2012; 28(6-7):605-11. PubMed ID: 22805136 [TBL] [Abstract][Full Text] [Related]
28. IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation. Morandi F; Di Carlo E; Ferrone S; Petretto A; Pistoia V; Airoldi I J Immunol; 2014 Mar; 192(6):2634-42. PubMed ID: 24554774 [TBL] [Abstract][Full Text] [Related]
29. Mutually assured destruction: the cold war between viruses and natural killer cells. Ali A; Gyurova IE; Waggoner SN Curr Opin Virol; 2019 Feb; 34():130-139. PubMed ID: 30877885 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-27: biological properties and clinical application. Jankowski M; Kopiński P; Goc A Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):417-25. PubMed ID: 20872282 [TBL] [Abstract][Full Text] [Related]
31. Important Role of the IL-32 Inflammatory Network in the Host Response against Viral Infection. Zhou Y; Zhu Y Viruses; 2015 Jun; 7(6):3116-29. PubMed ID: 26087456 [TBL] [Abstract][Full Text] [Related]
32. Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection. Xu HC; Huang J; Khairnar V; Duhan V; Pandyra AA; Grusdat M; Shinde P; McIlwain DR; Maney SK; Gommerman J; Löhning M; Ohashi PS; Mak TW; Pieper K; Sic H; Speletas M; Eibel H; Ware CF; Tumanov AV; Kruglov AA; Nedospasov SA; Häussinger D; Recher M; Lang KS; Lang PA J Virol; 2015 May; 89(9):4748-59. PubMed ID: 25673724 [TBL] [Abstract][Full Text] [Related]
33. New dog and new tricks: evolving roles for IL-33 in type 2 immunity. Lott JM; Sumpter TL; Turnquist HR J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770 [TBL] [Abstract][Full Text] [Related]
34. C-Type Lectin Receptors in Antiviral Immunity and Viral Escape. Bermejo-Jambrina M; Eder J; Helgers LC; Hertoghs N; Nijmeijer BM; Stunnenberg M; Geijtenbeek TBH Front Immunol; 2018; 9():590. PubMed ID: 29632536 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-155 and antiviral immune responses. Jafarzadeh A; Naseri A; Shojaie L; Nemati M; Jafarzadeh S; Bannazadeh Baghi H; Hamblin MR; Akhlagh SA; Mirzaei H Int Immunopharmacol; 2021 Dec; 101(Pt A):108188. PubMed ID: 34626873 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection. Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338 [TBL] [Abstract][Full Text] [Related]